Worldwide Facial Injectables Market Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Global Facial Injectables Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Skin provides a protective barrier to the body by covering all the core structures and is the largest organ in the human body. Skin acts as a mechanical barrier for harmful UV rays and plays a vital role in thermoregulation and water homeostasis. Aging is one of the direct comparisons of the chronological changes in the face, hair, body, and all the visible characteristics that are found comparative. Every individual face ages on its own speed and depends on various environmental factors. However, some basic characteristics are common and natural: loss of a proportion of the skin, glabellar lines, sagging of the eyebrows, sunken eyes, wrinkles, irregular skin surfaces, loss of lip volume, irregular chin contour, and skin discoloration. Apart from aging, the new generation has attracted towards cosmetic industry to look aesthetic and appear more youthful. Most of the advancements made in the dermatology field are to treat various skin diseases and enhance the quality of the skin. The advent of facial injectables has revolutionized the cosmetic industry by providing an individual the most important part of life, which is to look youthful and beautiful.
The factors such as increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical and minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is witnessing the emerging trends such as increase in demand for combination treatments, rise in medical tourism, and increase in disposable income that will drive the market at a significant pace during the forecast period. The markets in Brazil, India, China, and Russia are expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.
The major products in the market include:
Market Analysis: The “Global Facial Injectables Market” is estimated to witness a CAGR of 10.42% during the forecast period 2017–2023. The market is analyzed based on three segments – product type, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the facial injectables market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. Brazil is set to be the most attractive destination, and in Latin America, the popularity and the usage of facial injectables are expected to increase in the coming years.
Product Analysis: Botox and dermal fillers are the most popular treatments among all class of people and have become the most common aesthetic procedures among end-users. Botox dominated the market, while dermal fillers segment is positioned above due to the huge adoption of a wide variety of fillers owing to its growing use in many areas. In 2016, there were about 7.05 million injections of botulinum toxin worldwide. It is because of the shift in cultural thinking, high spending on beauty products, and increased brand popularity. On an average, women have started spending $300–$500 billion a year on beauty products. Moreover, advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing facial injections to patients. Further, the market is also witnessing various mergers, acquisitions, and collaborations among the top players, which are defining the future of the Global Facial Injectables market.
Key Players: Allergan plc, Galderma S.A., Merz Pharma Gmbh & Co. KGaA, Merck & Co. Inc., Ipsen S.A., and other predominate & niche players.
Competitive Analysis: The Global Facial Injectables market is highly fragmented and has immense growth opportunities for vendors, especially in the developed regions. The presence of large, small, and local vendors in the market possess high competition. The market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors have a strong focus on acquiring smaller companies and expanding their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&As. They form strategic alliances for the marketing or manufacturing of facial injectables products.
Benefits: The report provides complete details about the usage and adoption rate of facial injectables in various dermatology treatments. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the facial injectables adoption in the upcoming years along with the details of pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview: Skin provides a protective barrier to the body by covering all the core structures and is the largest organ in the human body. Skin acts as a mechanical barrier for harmful UV rays and plays a vital role in thermoregulation and water homeostasis. Aging is one of the direct comparisons of the chronological changes in the face, hair, body, and all the visible characteristics that are found comparative. Every individual face ages on its own speed and depends on various environmental factors. However, some basic characteristics are common and natural: loss of a proportion of the skin, glabellar lines, sagging of the eyebrows, sunken eyes, wrinkles, irregular skin surfaces, loss of lip volume, irregular chin contour, and skin discoloration. Apart from aging, the new generation has attracted towards cosmetic industry to look aesthetic and appear more youthful. Most of the advancements made in the dermatology field are to treat various skin diseases and enhance the quality of the skin. The advent of facial injectables has revolutionized the cosmetic industry by providing an individual the most important part of life, which is to look youthful and beautiful.
The factors such as increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical and minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is witnessing the emerging trends such as increase in demand for combination treatments, rise in medical tourism, and increase in disposable income that will drive the market at a significant pace during the forecast period. The markets in Brazil, India, China, and Russia are expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.
The major products in the market include:
- Restylane – Hyaluronic Acid-Based Filler
- Juvederm – Hyaluronic Acid-Based Filler
- PREVELLE Silk – Hyaluronic Acid-Based Filler
- Hydrelle – Hyaluronic Acid-Based Filler
- Belotero – Hyaluronic Acid-Based Filler
- Cosmoplast – Collagen-Based Fillers
- Evolence – Collagen-Based Fillers
- Sculptra – Semi-Permanent Fillers
- Radiesse – Semi-Permanent Fillers
- ArteFill – Permanent Fillers
- BOTOX – OnabotulinumtoxinA
- Dysport – AbobotulinumtoxinA
- Xeomin – IncobotulinumtoxinA
- Myobloc – RimabotulinumtoxinB
Market Analysis: The “Global Facial Injectables Market” is estimated to witness a CAGR of 10.42% during the forecast period 2017–2023. The market is analyzed based on three segments – product type, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the facial injectables market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. Brazil is set to be the most attractive destination, and in Latin America, the popularity and the usage of facial injectables are expected to increase in the coming years.
Product Analysis: Botox and dermal fillers are the most popular treatments among all class of people and have become the most common aesthetic procedures among end-users. Botox dominated the market, while dermal fillers segment is positioned above due to the huge adoption of a wide variety of fillers owing to its growing use in many areas. In 2016, there were about 7.05 million injections of botulinum toxin worldwide. It is because of the shift in cultural thinking, high spending on beauty products, and increased brand popularity. On an average, women have started spending $300–$500 billion a year on beauty products. Moreover, advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing facial injections to patients. Further, the market is also witnessing various mergers, acquisitions, and collaborations among the top players, which are defining the future of the Global Facial Injectables market.
Key Players: Allergan plc, Galderma S.A., Merz Pharma Gmbh & Co. KGaA, Merck & Co. Inc., Ipsen S.A., and other predominate & niche players.
Competitive Analysis: The Global Facial Injectables market is highly fragmented and has immense growth opportunities for vendors, especially in the developed regions. The presence of large, small, and local vendors in the market possess high competition. The market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors have a strong focus on acquiring smaller companies and expanding their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&As. They form strategic alliances for the marketing or manufacturing of facial injectables products.
Benefits: The report provides complete details about the usage and adoption rate of facial injectables in various dermatology treatments. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the facial injectables adoption in the upcoming years along with the details of pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 REPORT OUTLINE
1.1 Report Scope
1.2 Market Definitions
1.3 Research Methodology
1.4 Report Assumptions and Declarations
2 EXECUTIVE SUMMARY
3 MARKET POSITIONING
3.1 Total Addressable Market (TAM): Medical Aesthetics Industry
3.2 Segmented Addressable Market (SAM): Facial Injectables Market
3.2.1 Market Overview
3.2.2 Major Trends
3.2.3 PEST Analysis
3.3 Related Markets
4 MARKET OUTLOOK
4.1 Overview
4.2 Value Chain Analysis
4.3 Market Segmentation
4.4 Porter 5 (Five) Forces Analysis
4.5 Raw Material Analysis
4.6 Patents Analysis
5 MARKET CHARACTERISTICS
5.1 Ecosystem
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.2 Restraints
5.3.3 Opportunities
5.3.4 DRO – Impact Analysis
6 FACIAL INJECTABLES MARKET BY TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Dermal Fillers
6.3 Botox
7 FACIAL INJECTABLES MARKET BY END USERS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals
7.3 Dermatology Centers
7.4 Physician’s Office
8 FACIAL INJECTABLES MARKET BY REGIONS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 The Americas
7.3 The EMEA Region
7.4 The APAC region
8 COMPETITIVE LANDSCAPE
8.1 Overview
9 VENDOR PROFILES
9.1 Allergan Plc
8.2 Galderma S.A.
8.3 Merz Pharma GmbH & Co. KGaA
8.4 Ipsen S.A.
(Overview, products/services, geographic revenues, recent developments, business focus, SWOT analysis and business strategy for all vendors)
9 COMPANIES TO WATCH FOR
9.1 Sinclair Pharma Plc
9.2 Bloomage Biotechnology Corp. Ltd.
9.3 Valeant Pharmaceuticals International Inc.
(Overview, product coverage and potential, geographic exposure, recent developments, and business strategy for all players)
Annexure
Acronyms
1.1 Report Scope
1.2 Market Definitions
1.3 Research Methodology
1.4 Report Assumptions and Declarations
2 EXECUTIVE SUMMARY
3 MARKET POSITIONING
3.1 Total Addressable Market (TAM): Medical Aesthetics Industry
3.2 Segmented Addressable Market (SAM): Facial Injectables Market
3.2.1 Market Overview
3.2.2 Major Trends
3.2.3 PEST Analysis
3.3 Related Markets
4 MARKET OUTLOOK
4.1 Overview
4.2 Value Chain Analysis
4.3 Market Segmentation
4.4 Porter 5 (Five) Forces Analysis
4.5 Raw Material Analysis
4.6 Patents Analysis
5 MARKET CHARACTERISTICS
5.1 Ecosystem
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.2 Restraints
5.3.3 Opportunities
5.3.4 DRO – Impact Analysis
6 FACIAL INJECTABLES MARKET BY TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Dermal Fillers
6.3 Botox
7 FACIAL INJECTABLES MARKET BY END USERS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals
7.3 Dermatology Centers
7.4 Physician’s Office
8 FACIAL INJECTABLES MARKET BY REGIONS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 The Americas
7.3 The EMEA Region
7.4 The APAC region
8 COMPETITIVE LANDSCAPE
8.1 Overview
9 VENDOR PROFILES
9.1 Allergan Plc
8.2 Galderma S.A.
8.3 Merz Pharma GmbH & Co. KGaA
8.4 Ipsen S.A.
(Overview, products/services, geographic revenues, recent developments, business focus, SWOT analysis and business strategy for all vendors)
9 COMPANIES TO WATCH FOR
9.1 Sinclair Pharma Plc
9.2 Bloomage Biotechnology Corp. Ltd.
9.3 Valeant Pharmaceuticals International Inc.
(Overview, product coverage and potential, geographic exposure, recent developments, and business strategy for all players)
Annexure
Acronyms
LIST OF TABLES
Table 1 AVERAGE COST OF DERMAL FACIAL FILLERS
Table 2 GLOBAL FACIAL INJECTABLES MARKET BY TYPES, 2016–2023 ($MILLION)
Table 3 DRO OF DERMAL FILLERS MARKET
Table 4 DRO OF BOTOX MARKET
Table 5 GLOBAL FACIAL INJECTABLES MARKET REVENUE FORECAST BY REGION, 2017–2023 ($MILLION)
Table 6 DRO (NORTH AMERICA)
Table 7 DRO (EUROPE)
Table 8 DRO (APAC)
Table 9 DRO (REST OF THE WORLD)
Table 10 GLOBAL FACIAL INJECTABLES MARKET BY VENDOR RANKING, 2016
Table 11 ALLERGAN PLC: PRODUCT OFFERINGS
Table 12 ALLERGAN PLC: RECENT DEVELOPMENTS
Table 13 GALDERMA S.A.: PRODUCT OFFERINGS
Table 14 GALDERMA S.A.: RECENT DEVELOPMENTS
Table 15 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS
Table 16 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS
Table 17 IPSEN S.A.: PRODUCT OFFERINGS
Table 18 IPSEN S.A.: RECENT DEVELOPMENTS
Table 19 SINCLAIR PHARMA PLC: SNAPSHOT
Table 20 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS
Table 21 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT
Table 22 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS
Table 23 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT
Table 24 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS
Table 25 OTHER VENDORS
Table 1 AVERAGE COST OF DERMAL FACIAL FILLERS
Table 2 GLOBAL FACIAL INJECTABLES MARKET BY TYPES, 2016–2023 ($MILLION)
Table 3 DRO OF DERMAL FILLERS MARKET
Table 4 DRO OF BOTOX MARKET
Table 5 GLOBAL FACIAL INJECTABLES MARKET REVENUE FORECAST BY REGION, 2017–2023 ($MILLION)
Table 6 DRO (NORTH AMERICA)
Table 7 DRO (EUROPE)
Table 8 DRO (APAC)
Table 9 DRO (REST OF THE WORLD)
Table 10 GLOBAL FACIAL INJECTABLES MARKET BY VENDOR RANKING, 2016
Table 11 ALLERGAN PLC: PRODUCT OFFERINGS
Table 12 ALLERGAN PLC: RECENT DEVELOPMENTS
Table 13 GALDERMA S.A.: PRODUCT OFFERINGS
Table 14 GALDERMA S.A.: RECENT DEVELOPMENTS
Table 15 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS
Table 16 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS
Table 17 IPSEN S.A.: PRODUCT OFFERINGS
Table 18 IPSEN S.A.: RECENT DEVELOPMENTS
Table 19 SINCLAIR PHARMA PLC: SNAPSHOT
Table 20 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS
Table 21 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT
Table 22 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS
Table 23 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT
Table 24 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS
Table 25 OTHER VENDORS
LIST OF CHARTS
Chart 1 FACIAL INJECTABLES SEGMENTATION BY AESTHETICS TYPES
Chart 2 MATERIALS USED IN SOFT TISSUE FILLERS
Chart 3 NUMBER OF AESTHETIC PROCEDURES PERFORMED IN THE AMERICAS
Chart 4 TOP FIVE NON-SURGICAL PROCEDURES IN 2016
Chart 5 PEST ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET
Chart 6 RESEARCH METHODOLOGY OF GLOBAL FACIAL INJECTABLES MARKET
Chart 7 WORLDWIDE FACIAL INJECTABLES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 8 PORTER 5 FORCES ON GLOBAL FACIAL INJECTABLES MARKET
Chart 9 FILLER MARKET EVOLUTION IN THE US
Chart 10 FACIAL INJECTABLES – DRO ANALYSIS
Chart 11 DRO – IMPACT ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET
Chart 12 KEY STAKEHOLDERS
Chart 13 GLOBAL FACIAL INJECTABLES MARKET BY TYPE SEGMENTATION, 2016 (%)
Chart 14 GLOBAL FACIAL INJECTABLES MARKET ATTRACTIVENESS BY PRODUCT TYPES, 2016
Chart 15 WORLDWIDE DERMAL FILLERS MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 16 WORLDWIDE BOTOX MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 17 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION SHARE BY PRODUCT TYPE, 2017-2023 ($MILLION)
Chart 18 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION SHARE BY PRODUCT TYPE, 2017–2023 (%)
Chart 19 GLOBAL FACIAL INJECTABLES MARKET SHARE BY END-USER SEGMENTATION, 2016 (%)
Chart 20 BUYING CRITERIA
Chart 21 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 22 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)
Chart 23 GLOBAL FACIAL INJECTABLES MARKET ATTRACTIVENESS BY REGIONS, 2016
Chart 24 FACIAL INJECTABLES MARKET REVENUE IN NORTH AMERICA, 2017–2023 ($MILLION)
Chart 25 FACIAL INJECTABLES MARKET REVENUE IN EUROPE, 2017–2023 ($MILLION)
Chart 26 FACIAL INJECTABLES MARKET REVENUE IN THE APAC REGION, 2017–2023 ($MILLION)
Chart 27 FACIAL INJECTABLES MARKET REVENUE IN THE REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 28 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY REGIONS, 2016–2023 ($MILLION)
Chart 29 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY REGIONS, 2016-2023 (%)
Chart 30 ALLERGAN PLC: OVERVIEW SNAPSHOT
Chart 31 ALLERGAN PLC: BUSINESS UNITS
Chart 32 ALLERGAN PLC: SWOT ANALYSIS
Chart 33 GALDERMA S.A.: OVERVIEW SNAPSHOT
Chart 34 GALDERMA S.A.: GEOGRAPHIC PRESENCE
Chart 35 GALDERMA S.A.: SWOT ANALYSIS
Chart 36 MERZ PHARMA GMBH & CO. KGAA: OVERVIEW SNAPSHOT
Chart 37 MERZ PHARMA GMBH & CO. KGAA: GEOGRAPHIC PRESENCE
Chart 38 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
Chart 39 IPSEN S.A.: OVERVIEW SNAPSHOT
Chart 40 IPSEN S.A.: BUSINESS UNITS
Chart 41 IPSEN S.A.: GEOGRAPHIC PRESENCE
Chart 42 IPSEN S.A.: SWOT ANALYSIS
Chart 1 FACIAL INJECTABLES SEGMENTATION BY AESTHETICS TYPES
Chart 2 MATERIALS USED IN SOFT TISSUE FILLERS
Chart 3 NUMBER OF AESTHETIC PROCEDURES PERFORMED IN THE AMERICAS
Chart 4 TOP FIVE NON-SURGICAL PROCEDURES IN 2016
Chart 5 PEST ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET
Chart 6 RESEARCH METHODOLOGY OF GLOBAL FACIAL INJECTABLES MARKET
Chart 7 WORLDWIDE FACIAL INJECTABLES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 8 PORTER 5 FORCES ON GLOBAL FACIAL INJECTABLES MARKET
Chart 9 FILLER MARKET EVOLUTION IN THE US
Chart 10 FACIAL INJECTABLES – DRO ANALYSIS
Chart 11 DRO – IMPACT ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET
Chart 12 KEY STAKEHOLDERS
Chart 13 GLOBAL FACIAL INJECTABLES MARKET BY TYPE SEGMENTATION, 2016 (%)
Chart 14 GLOBAL FACIAL INJECTABLES MARKET ATTRACTIVENESS BY PRODUCT TYPES, 2016
Chart 15 WORLDWIDE DERMAL FILLERS MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 16 WORLDWIDE BOTOX MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 17 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION SHARE BY PRODUCT TYPE, 2017-2023 ($MILLION)
Chart 18 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION SHARE BY PRODUCT TYPE, 2017–2023 (%)
Chart 19 GLOBAL FACIAL INJECTABLES MARKET SHARE BY END-USER SEGMENTATION, 2016 (%)
Chart 20 BUYING CRITERIA
Chart 21 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 22 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)
Chart 23 GLOBAL FACIAL INJECTABLES MARKET ATTRACTIVENESS BY REGIONS, 2016
Chart 24 FACIAL INJECTABLES MARKET REVENUE IN NORTH AMERICA, 2017–2023 ($MILLION)
Chart 25 FACIAL INJECTABLES MARKET REVENUE IN EUROPE, 2017–2023 ($MILLION)
Chart 26 FACIAL INJECTABLES MARKET REVENUE IN THE APAC REGION, 2017–2023 ($MILLION)
Chart 27 FACIAL INJECTABLES MARKET REVENUE IN THE REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 28 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY REGIONS, 2016–2023 ($MILLION)
Chart 29 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY REGIONS, 2016-2023 (%)
Chart 30 ALLERGAN PLC: OVERVIEW SNAPSHOT
Chart 31 ALLERGAN PLC: BUSINESS UNITS
Chart 32 ALLERGAN PLC: SWOT ANALYSIS
Chart 33 GALDERMA S.A.: OVERVIEW SNAPSHOT
Chart 34 GALDERMA S.A.: GEOGRAPHIC PRESENCE
Chart 35 GALDERMA S.A.: SWOT ANALYSIS
Chart 36 MERZ PHARMA GMBH & CO. KGAA: OVERVIEW SNAPSHOT
Chart 37 MERZ PHARMA GMBH & CO. KGAA: GEOGRAPHIC PRESENCE
Chart 38 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
Chart 39 IPSEN S.A.: OVERVIEW SNAPSHOT
Chart 40 IPSEN S.A.: BUSINESS UNITS
Chart 41 IPSEN S.A.: GEOGRAPHIC PRESENCE
Chart 42 IPSEN S.A.: SWOT ANALYSIS
